REAL WORLD COMPARISON OF RENAL SAFETY IN PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VS TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B

被引：0
|
作者：
Zhang, Xueyun [1 ]
Hu, Qiankun [2 ]
Liu, Xiaoqin [1 ]
Huang, Yuxian [1 ]
机构：
[1] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China
[2] Fudan Univ, Dept Liver Dis, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
799
引用
收藏
页码：490A / 491A
页数：2
相关论文
共 50 条
  • [1] COMPARATIVE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS
    Yu, N. Y.
    Chang, K. C.
    VALUE IN HEALTH, 2020, 23 : S532 - S532
  • [2] RENAL AND BONE SAFETY OF TENOFOVIR ALAFENAMIDE VS TENOFOVIR DISOPROXIL FUMARATE
    Post, Frank
    Sax, Paul
    Saag, Michael
    Yin, Michael
    Oka, Shinichi
    Koenig, Ellen
    Trottier, Benoit
    Andrade, Jaime
    Cao, Huyen
    Fordyce, Marshall
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A48 - +
  • [3] Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01) : 49 - 63
  • [4] Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B
    Jeong, Sara
    Shin, Hyun Phil
    Kim, Ha Il
    INTERVIROLOGY, 2022, 65 (02) : 94 - 103
  • [5] Reply to correspondence on "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide"
    Cheng, Pin-Nan
    Yu, Ming-Lung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [6] Comparable risk of cardiovascular events in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Jonggi
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1139 - S1139
  • [7] Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
    Lin, Shenglong
    Huang, Wanlong
    Liao, Ziyuan
    Ma, Huaxi
    Wu, Wenjun
    Lin, Minghua
    Huang, Defu
    Gao, Haibing
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [8] Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
    Su, Pei-Yuan
    Su, Wei-Wen
    Hsu, Yu-Chun
    Huang, Siou-Ping
    Yen, Hsu-Heng
    PEERJ, 2021, 9
  • [9] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive patients with chronic hepatitis B
    Lim, Jihye
    Choi, Won-Mook
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    JOURNAL OF HEPATOLOGY, 2022, 77 : S842 - S842
  • [10] Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
    Lee, Hye Won
    Cho, Young Youn
    Lee, Hyein
    Lee, Jae Seung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Beom Kyung
    Park, Soo Young
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (11) : 1570 - 1578
12345